Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crescera Capital is a Brazilian private equity and venture capital investment firm rather than a life science, biotech, pharma, or healthcare operating company. The firm invests in middle-market and high-growth businesses across several sectors, including healthcare, education, consumer, retail, logistics, innovation, and technology. Crescera has operated in the Brazilian market since 2008 through predecessor firms including BR Investimentos and Bozano Investimentos, and presents itself as an independent asset manager focused on value creation and hands-on governance. While it has made healthcare-related investments, it does not appear to develop therapeutics, diagnostics, or medical products itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crescera.